SI2890687T1 - Soli benzotiazolonske spojine kot agonist beta-2-adrenoceptorja - Google Patents
Soli benzotiazolonske spojine kot agonist beta-2-adrenoceptorjaInfo
- Publication number
- SI2890687T1 SI2890687T1 SI201330750T SI201330750T SI2890687T1 SI 2890687 T1 SI2890687 T1 SI 2890687T1 SI 201330750 T SI201330750 T SI 201330750T SI 201330750 T SI201330750 T SI 201330750T SI 2890687 T1 SI2890687 T1 SI 2890687T1
- Authority
- SI
- Slovenia
- Prior art keywords
- beta
- salts
- adrenoceptor agonist
- benzothiazolone compound
- benzothiazolone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IQ23912 | 2012-08-30 | ||
| PCT/IB2013/058109 WO2014033654A1 (en) | 2012-08-30 | 2013-08-29 | Salts of benzothiazolone compound as beta-2-adrenoceptor agonist |
| EP13812075.3A EP2890687B1 (en) | 2012-08-30 | 2013-08-29 | Salts of benzothiazolone compound as beta-2-adrenoceptor agonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2890687T1 true SI2890687T1 (sl) | 2017-10-30 |
Family
ID=53386469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201330750T SI2890687T1 (sl) | 2012-08-30 | 2013-08-29 | Soli benzotiazolonske spojine kot agonist beta-2-adrenoceptorja |
Country Status (27)
| Country | Link |
|---|---|
| EP (2) | EP3243817A1 (sl) |
| KR (1) | KR20150047586A (sl) |
| CN (2) | CN104736525B (sl) |
| BR (1) | BR112015004127A2 (sl) |
| CA (1) | CA2882877A1 (sl) |
| CL (1) | CL2015000461A1 (sl) |
| CY (1) | CY1120225T1 (sl) |
| DK (1) | DK2890687T3 (sl) |
| EA (1) | EA029946B1 (sl) |
| ES (1) | ES2642003T3 (sl) |
| HK (1) | HK1206015A1 (sl) |
| HR (1) | HRP20171362T1 (sl) |
| HU (1) | HUE033655T2 (sl) |
| IL (1) | IL237382A0 (sl) |
| LT (1) | LT2890687T (sl) |
| MA (1) | MA37872A1 (sl) |
| MX (1) | MX351741B (sl) |
| MY (1) | MY169038A (sl) |
| NZ (1) | NZ705319A (sl) |
| PE (1) | PE20150465A1 (sl) |
| PL (1) | PL2890687T3 (sl) |
| PT (1) | PT2890687T (sl) |
| SA (1) | SA515360076B1 (sl) |
| SG (2) | SG10201704377PA (sl) |
| SI (1) | SI2890687T1 (sl) |
| TN (1) | TN2015000058A1 (sl) |
| WO (1) | WO2014033654A1 (sl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3192B1 (ar) * | 2011-09-06 | 2018-03-08 | Novartis Ag | مركب بنزوثيازولون |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004078163A2 (en) | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| AR040962A1 (es) | 2002-08-09 | 2005-04-27 | Novartis Ag | Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto |
| WO2005110990A1 (de) | 2004-05-13 | 2005-11-24 | Boehringer Ingelheim International Gmbh | Hydroxy-substituierte benzkondensierte heterozyklen als betaagonisten zur behandlung von atemwegserkrankungen |
| GB0426164D0 (en) * | 2004-11-29 | 2004-12-29 | Novartis Ag | Organic compounds |
| JO3192B1 (ar) * | 2011-09-06 | 2018-03-08 | Novartis Ag | مركب بنزوثيازولون |
| WO2014132205A1 (en) * | 2013-02-28 | 2014-09-04 | Novartis Ag | Formulation comprising benzothiazolone compound |
-
2013
- 2013-08-29 BR BR112015004127A patent/BR112015004127A2/pt not_active Application Discontinuation
- 2013-08-29 MA MA37872A patent/MA37872A1/fr unknown
- 2013-08-29 CA CA2882877A patent/CA2882877A1/en not_active Abandoned
- 2013-08-29 SG SG10201704377PA patent/SG10201704377PA/en unknown
- 2013-08-29 KR KR1020157007573A patent/KR20150047586A/ko not_active Application Discontinuation
- 2013-08-29 ES ES13812075.3T patent/ES2642003T3/es active Active
- 2013-08-29 CN CN201380055093.1A patent/CN104736525B/zh not_active Expired - Fee Related
- 2013-08-29 WO PCT/IB2013/058109 patent/WO2014033654A1/en active Application Filing
- 2013-08-29 HU HUE13812075A patent/HUE033655T2/en unknown
- 2013-08-29 SI SI201330750T patent/SI2890687T1/sl unknown
- 2013-08-29 PE PE2015000275A patent/PE20150465A1/es not_active Application Discontinuation
- 2013-08-29 LT LTEP13812075.3T patent/LT2890687T/lt unknown
- 2013-08-29 CN CN201610537241.9A patent/CN106146428A/zh active Pending
- 2013-08-29 NZ NZ705319A patent/NZ705319A/en not_active IP Right Cessation
- 2013-08-29 MX MX2015002656A patent/MX351741B/es active IP Right Grant
- 2013-08-29 PT PT138120753T patent/PT2890687T/pt unknown
- 2013-08-29 EP EP17171708.5A patent/EP3243817A1/en not_active Withdrawn
- 2013-08-29 DK DK13812075.3T patent/DK2890687T3/en active
- 2013-08-29 PL PL13812075T patent/PL2890687T3/pl unknown
- 2013-08-29 EA EA201590452A patent/EA029946B1/ru not_active IP Right Cessation
- 2013-08-29 MY MYPI2015000453A patent/MY169038A/en unknown
- 2013-08-29 SG SG11201501293PA patent/SG11201501293PA/en unknown
- 2013-08-29 EP EP13812075.3A patent/EP2890687B1/en active Active
-
2015
- 2015-02-20 TN TNP2015000058A patent/TN2015000058A1/fr unknown
- 2015-02-23 IL IL237382A patent/IL237382A0/en unknown
- 2015-02-25 CL CL2015000461A patent/CL2015000461A1/es unknown
- 2015-02-26 SA SA515360076A patent/SA515360076B1/ar unknown
- 2015-07-08 HK HK15106522.7A patent/HK1206015A1/xx not_active IP Right Cessation
-
2017
- 2017-09-11 HR HRP20171362TT patent/HRP20171362T1/hr unknown
- 2017-09-13 CY CY20171100967T patent/CY1120225T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SA515360076B1 (ar) | 2016-03-20 |
| CA2882877A1 (en) | 2014-03-06 |
| CL2015000461A1 (es) | 2015-05-04 |
| CY1120225T1 (el) | 2018-12-12 |
| CN106146428A (zh) | 2016-11-23 |
| IL237382A0 (en) | 2015-04-30 |
| MY169038A (en) | 2019-02-07 |
| ES2642003T3 (es) | 2017-11-14 |
| PL2890687T3 (pl) | 2017-11-30 |
| BR112015004127A2 (pt) | 2017-07-04 |
| TN2015000058A1 (en) | 2016-06-29 |
| WO2014033654A1 (en) | 2014-03-06 |
| MA37872A1 (fr) | 2018-07-31 |
| EA029946B1 (ru) | 2018-06-29 |
| NZ705319A (en) | 2018-05-25 |
| PE20150465A1 (es) | 2015-04-22 |
| SG11201501293PA (en) | 2015-03-30 |
| HRP20171362T1 (hr) | 2017-11-03 |
| CN104736525B (zh) | 2016-08-24 |
| LT2890687T (lt) | 2017-09-11 |
| EP3243817A1 (en) | 2017-11-15 |
| HUE033655T2 (en) | 2017-12-28 |
| DK2890687T3 (en) | 2017-10-09 |
| EP2890687B1 (en) | 2017-06-28 |
| CN104736525A (zh) | 2015-06-24 |
| SG10201704377PA (en) | 2017-06-29 |
| EA201590452A1 (ru) | 2015-07-30 |
| MX351741B (es) | 2017-10-26 |
| KR20150047586A (ko) | 2015-05-04 |
| EP2890687A1 (en) | 2015-07-08 |
| MX2015002656A (es) | 2015-05-20 |
| PT2890687T (pt) | 2017-10-05 |
| HK1206015A1 (en) | 2015-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1206339A1 (en) | N-aryltriazole compounds as lpar antagonists lpar n- | |
| HK1206342A1 (en) | N-alkyltriazole compounds as lpar antagonists lpar n- | |
| HK1187259A1 (zh) | 取代的喹啉化合物 | |
| IL232599A (en) | Hydrobromide salt of peridofidine | |
| EP2738170A4 (en) | HETEROCYCLIC COMPOUND | |
| HK1210769A1 (en) | Heterocyclic compound | |
| EP2889291A4 (en) | HETEROCYCLIC CONNECTION | |
| HK1190707A1 (zh) | 作為 激動劑的 -氨基-吡啶類 | |
| EP2873669A4 (en) | HETEROCYCLIC COMPOUND | |
| EP2832734A4 (en) | HETEROCYCLIC CONNECTION | |
| EP2818473A4 (en) | HETEROCYCLIC COMPOUND | |
| EP2927229A4 (en) | HETEROCYCLIC COMPOUND | |
| EP2906542A4 (en) | SUBSTITUTED SPIROPIPERIDINYL COMPOUNDS USEFUL AS AGONISTS OF GPR120 | |
| EP2857400A4 (en) | HETEROCYCLIC COMPOUND | |
| ZA201500790B (en) | Benzothiazolone compound | |
| EP2680843A4 (en) | DERIVATIVES OF PYRAZOLSUBSTITUTED AMINO-HETEROARYL COMPOUNDS | |
| HK1212213A1 (en) | Formulation comprising benzothiazolone compound | |
| HRP20171362T1 (hr) | Soli benzotiazolonskog spoja koje služe kao agonist beta-2-adrenoceptora | |
| GB201108347D0 (en) | Polymprphic form of compound | |
| GB201108346D0 (en) | Polymorphic form of compound |